<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1220"/><api:result><api:object category="publication" id="1220" last-affected-when="2024-04-14T23:54:36.59+01:00" last-modified-when="2024-04-14T23:54:36.59+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1220" created-when="2010-05-17T13:47:33.81+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2012-10-15</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1492059" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.2165/00019053-200017040-00004" last-modified-when="2022-09-10T13:24:38.757+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Oâ€™Hagan</api:last-name><api:initials>A</api:initials><api:first-names>Anthony</api:first-names><api:separate-first-names><api:first-name>Anthony</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="191" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/191"/></api:links><api:last-name>Stevens</api:last-name><api:initials>JW</api:initials><api:first-names>John W</api:first-names><api:separate-first-names><api:first-name>John</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Montmartin</api:last-name><api:initials>J</api:initials><api:first-names>Jacques</api:first-names><api:separate-first-names><api:first-name>Jacques</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017040-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017040-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017040-00004"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1179-2027</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>15</api:day><api:month>10</api:month><api:year>2012</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>339</api:begin-page><api:end-page>349</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.2165/00019053-200017040-00004</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>12</api:day><api:month>11</api:month><api:year>2017</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="95814" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0034010546" last-modified-when="2023-11-22T06:27:32.007+00:00"><api:citation-count>75</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The aim of this article is to consider Bayesian and frequentist inference methods for measures of incremental cost effectiveness in data obtained via a clinical trial. The most useful measure is the cost- effectiveness (C/E) acceptability curve. Recent publications on Bayesian estimation have assumed a normal posterior distribution, which ignores uncertainty in estimated variances, and suggest unnecessarily complicated methods of computation. We present a simple Bayesian computation for the C/E acceptability curve and a simple frequentist analogue. Our approach takes account of errors in estimated variances, resulting in calculations that are based on distributions rather than normal distributions. If inference is required about the C/E ratio, we argue that the standard frequentist procedures give unreliable or misleading inferences, and present instead a Bayesian interval.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>O'Hagan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7003865198</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="191" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/191"/></api:links><api:last-name>Stevens</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">AstraZeneca</api:line><api:line type="city">Cambridge</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7403174948</api:identifier></api:identifiers></api:person><api:person><api:last-name>Montmartin</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">AstraZeneca</api:line><api:line type="city">Cambridge</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6506864637</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017040-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017040-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017040-00004"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10947489</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>339</api:begin-page><api:end-page>349</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inference for the cost-effectiveness acceptability curve and cost- effectiveness ratio</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="1220" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10947489" last-modified-when="2020-04-29T06:12:04.043+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The aim of this article is to consider Bayesian and frequentist inference methods for measures of incremental cost effectiveness in data obtained via a clinical trial. The most useful measure is the cost-effectiveness (C/E) acceptability curve. Recent publications on Bayesian estimation have assumed a normal posterior distribution, which ignores uncertainty in estimated variances, and suggest unnecessarily complicated methods of computation. We present a simple Bayesian computation for the C/E acceptability curve and a simple frequentist analogue. Our approach takes account of errors in estimated variances, resulting in calculations that are based on distributions rather than normal distributions. If inference is required about the C/E ratio, we argue that the standard frequentist procedures give unreliable or misleading inferences, and present instead a Bayesian interval.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>O'Hagan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Statistical Services Unit, University of Sheffield, South Yorkshire, England. a.ohagan@sheffield.ac.uk</api:line></api:address></api:addresses><api:email-address>a.ohagan@sheffield.ac.uk</api:email-address></api:person><api:person><api:links><api:link type="elements/user" id="191" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/191"/></api:links><api:last-name>Stevens</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Montmartin</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10947489</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017040-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017040-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017040-00004"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Pharmacoeconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Antirheumatic Agents</api:keyword><api:keyword scheme="mesh">Bayes Theorem</api:keyword><api:keyword scheme="mesh">Clinical Trials as Topic</api:keyword><api:keyword scheme="mesh">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin 1 Receptor Antagonist Protein</api:keyword><api:keyword scheme="mesh">Sialoglycoproteins</api:keyword><api:keyword scheme="mesh">Survival Rate</api:keyword><api:keyword scheme="mesh">Systemic Inflammatory Response Syndrome</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>New Zealand</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>339</api:begin-page><api:end-page>349</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>19</api:day><api:month>7</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="882318" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10947489" last-modified-when="2020-06-09T17:58:05.35+01:00"><api:citation-count>50</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The aim of this article is to consider Bayesian and frequentist inference methods for measures of incremental cost effectiveness in data obtained via a clinical trial. The most useful measure is the cost-effectiveness (C/E) acceptability curve. Recent publications on Bayesian estimation have assumed a normal posterior distribution, which ignores uncertainty in estimated variances, and suggest unnecessarily complicated methods of computation. We present a simple Bayesian computation for the C/E acceptability curve and a simple frequentist analogue. Our approach takes account of errors in estimated variances, resulting in calculations that are based on distributions rather than normal distributions. If inference is required about the C/E ratio, we argue that the standard frequentist procedures give unreliable or misleading inferences, and present instead a Bayesian interval.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Statistical Services Unit, University of Sheffield, South Yorkshire, England. a.ohagan@sheffield.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>O'Hagan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-7994-0702</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="191" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/191"/></api:links><api:last-name>Stevens</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Montmartin</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017040-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017040-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017040-00004"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1179-2027</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10947489</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Sialoglycoproteins</api:keyword><api:keyword scheme="mesh">Antirheumatic Agents</api:keyword><api:keyword scheme="mesh">Survival Rate</api:keyword><api:keyword scheme="mesh">Bayes Theorem</api:keyword><api:keyword scheme="mesh">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh">Systemic Inflammatory Response Syndrome</api:keyword><api:keyword scheme="mesh">Interleukin 1 Receptor Antagonist Protein</api:keyword><api:keyword scheme="mesh">Clinical Trials as Topic</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>339</api:begin-page><api:end-page>349</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="2483139" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1004296215" last-modified-when="2024-04-14T23:54:36.593+01:00"><api:citation-count>71</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>5</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Oâ€™Hagan</api:last-name><api:initials>A</api:initials><api:first-names>Anthony</api:first-names><api:separate-first-names><api:first-name>Anthony</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0773232711.35</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:links><api:link type="elements/user" id="191" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/191"/></api:links><api:last-name>Stevens</api:last-name><api:initials>JW</api:initials><api:first-names>John W</api:first-names><api:separate-first-names><api:first-name>John</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Astra CharnwoodLoughborough, Leicestershire, England</api:line><api:line type="state">England</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0700537170.06</api:identifier></api:identifiers></api:person><api:person><api:last-name>Montmartin</api:last-name><api:initials>J</api:initials><api:first-names>Jacques</api:first-names><api:separate-first-names><api:first-name>Jacques</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Astra CharnwoodLoughborough, Leicestershire, England</api:line><api:line type="state">England</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0726636235.07</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017040-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017040-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017040-00004"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10947489</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>14.94</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">38 Economics</api:keyword><api:keyword scheme="for-2020">3801 Applied Economics</api:keyword><api:keyword scheme="rcdc">Comparative Effectiveness Research</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="rcdc">Health Services</api:keyword><api:keyword scheme="rcdc">Cost Effectiveness Research</api:keyword><api:keyword scheme="mesh">Antirheumatic Agents</api:keyword><api:keyword scheme="mesh">Bayes Theorem</api:keyword><api:keyword scheme="mesh">Clinical Trials as Topic</api:keyword><api:keyword scheme="mesh">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin 1 Receptor Antagonist Protein</api:keyword><api:keyword scheme="mesh">Sialoglycoproteins</api:keyword><api:keyword scheme="mesh">Survival Rate</api:keyword><api:keyword scheme="mesh">Systemic Inflammatory Response Syndrome</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>15</api:day><api:month>10</api:month><api:year>2012</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>339</api:begin-page><api:end-page>349</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>2.14</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="241545" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000086579500004" last-modified-when="2024-03-14T05:57:47.967+00:00"><api:citation-count>61</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>O'Hagan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="191" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/191"/></api:links><api:last-name>Stevens</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Montmartin</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000086579500004&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-200017040-00004</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-200017040-00004"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-200017040-00004"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1179-2027</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">306CR</api:identifier><api:identifier scheme="pubmed">10947489</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PHARMACOECONOMICS</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>339</api:begin-page><api:end-page>349</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="24607" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000086579500004" last-modified-when="2014-07-25T11:08:10.703+01:00"><api:citation-count>43</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>O'Hagan</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="191" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/191"/></api:links><api:last-name>Stevens</api:last-name><api:initials>JW</api:initials><api:first-names>JW</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Montmartin</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PHARMACOECONOMICS</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>CONFIDENCE-INTERVALS</api:keyword><api:keyword>HEALTH</api:keyword><api:keyword>TRIAL</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>339</api:begin-page><api:end-page>349</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="1292359" source-id="12" source-name="repec" source-display-name="RePEc" id-at-source="RePEc:wkh:phecon:v:17:y:2000:i:4:p:339-349" suspected-deleted-at-source="true" last-modified-when="2024-04-09T15:51:50.48+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The aim of this article is to consider Bayesian and frequentist inference methods for measures of incremental cost effectiveness in data obtained via a clinical trial. The most useful measure is the cost-effectiveness (C/E) acceptability curve. Recent publications on Bayesian estimation have assumed a normal posterior distribution, which ignores uncertainty in estimated variances, and suggest unnecessarily complicated methods of computation. We present a simple Bayesian computation for the C/E acceptability curve and a simple frequentist analogue. Our approach takes account of errors in estimated variances, resulting in calculations that are based on distributions rather than normal distributions. If inference is required about the C/E ratio, we argue that the standard frequentist procedures give unreliable or misleading inferences, and present instead a Bayesian interval.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address><api:line type="organisation">Statistical Services Unit, University of Sheffield, Sheffield, South Yorkshire, England</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>O'Hagan</api:last-name><api:initials>A</api:initials><api:first-names>Anthony</api:first-names><api:separate-first-names><api:first-name>Anthony</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="191" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/191"/></api:links><api:last-name>Stevens</api:last-name><api:initials>J</api:initials><api:first-names>John</api:first-names><api:separate-first-names><api:first-name>John</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Montmartin</api:last-name><api:initials>J</api:initials><api:first-names>Jacques</api:first-names><api:separate-first-names><api:first-name>Jacques</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>C</api:keyword><api:keyword>D</api:keyword><api:keyword>I</api:keyword><api:keyword>Z</api:keyword><api:keyword>I1</api:keyword><api:keyword>I19</api:keyword><api:keyword>I18</api:keyword><api:keyword>I11</api:keyword><api:keyword>Cost effectiveness</api:keyword><api:keyword>Pharmacoeconomics</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>339</api:begin-page><api:end-page>349</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antirheumatic Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Bayes Theorem</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Clinical Trials as Topic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Interleukin 1 Receptor Antagonist Protein</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Sialoglycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Survival Rate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Systemic Inflammatory Response Syndrome</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Sialoglycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antirheumatic Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Survival Rate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Bayes Theorem</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Systemic Inflammatory Response Syndrome</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Interleukin 1 Receptor Antagonist Protein</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Clinical Trials as Topic</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">38 Economics</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3801 Applied Economics</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Comparative Effectiveness Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Health Services</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cost Effectiveness Research</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antirheumatic Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Bayes Theorem</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Clinical Trials as Topic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Interleukin 1 Receptor Antagonist Protein</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Sialoglycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Survival Rate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Systemic Inflammatory Response Syndrome</api:keyword><api:keyword origin="record-data" source="wos">CONFIDENCE-INTERVALS</api:keyword><api:keyword origin="record-data" source="wos">HEALTH</api:keyword><api:keyword origin="record-data" source="wos">TRIAL</api:keyword><api:keyword origin="record-data" source="repec">C</api:keyword><api:keyword origin="record-data" source="repec">D</api:keyword><api:keyword origin="record-data" source="repec">I</api:keyword><api:keyword origin="record-data" source="repec">Z</api:keyword><api:keyword origin="record-data" source="repec">I1</api:keyword><api:keyword origin="record-data" source="repec">I19</api:keyword><api:keyword origin="record-data" source="repec">I18</api:keyword><api:keyword origin="record-data" source="repec">I11</api:keyword><api:keyword origin="record-data" source="repec">Cost effectiveness</api:keyword><api:keyword origin="record-data" source="repec">Pharmacoeconomics</api:keyword><api:keyword scheme="for" origin="issn-inferred">11 Medical and Health Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">14 Economics</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Health Policy &amp; Services</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3214 Pharmacology and pharmaceutical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3801 Applied economics</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">4203 Health services and systems</api:keyword></api:keywords></api:all-labels><api:journal issn="1170-7690" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037" title="PharmacoEconomics (Auckland)"><api:records><api:record source-name="summary"><api:title>PharmacoEconomics (Auckland)</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1220/relationships"/></api:object></api:result></api:response>